Risk factors for adverse drug events: A 10-year analysis

被引:99
|
作者
Evans, RS
Lloyd, JF
Stoddard, GJ
Nebeker, JR
Samore, MH
机构
[1] LDS Hosp, Dept Med Informat, Salt Lake City, UT 84143 USA
[2] Univ Utah, Sch Med, LDS Hosp & Intermt Hlth Care, Salt Lake City, UT USA
[3] Univ Utah, Sch Med, Div Clin Epidemiol, Biostat Sect, Salt Lake City, UT 84112 USA
[4] Univ Utah, Sch Med, Div Clin Epidemiol, Salt Lake City, UT 84112 USA
[5] Univ Utah, Sch Med, Dept Med Informat, Salt Lake City, UT USA
关键词
adverse drug events; quality improvement; risk factors;
D O I
10.1345/aph.1E642
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Many adverse drug events (ADEs) are the result of known pharmacologic properties, and some result from medication errors. However, some are the result of patient-specific risk factors. OBJECTIVE: To identify inpatient risk factors for ADEs. METHODS: Conditional logistic regression was used to analyze all pharmacist-verified ADEs by therapeutic class of drugs and severity during a 10-year study period. All inpatients >= 18 years of age from a 520-bed tertiary teaching hospital were included. Each case patient was matched with up to 16 control patients. Odds ratios for patient factors associated with ADEs were calculated from different therapeutic classes of drugs. RESULTS: Odds ratios for numerous risk factors were identified for 4376 ADEs and were found to vary depending on therapeutic classification. The risk factors for the different classifications were grouped by (1) patient characteristics-female (OR 1.5-1.7), age (0.7-0.9), weight (1.2-1.4), creatinine clearance (0.8-4.7), and number of comorbidities (1.1-12.6); (2) drug administration-dosage (1.2-3.7), administration route (1.4-149.9), and number of concomitant drugs (1.2-2.4); and (3) patient type-service (1.2-4.9), nursing division (1.5-3.8), and diagnosis-related group (1.5-5.7). CONCLUSIONS: Some risk factors are consistent for all ADEs and across multiple therapeutic classes of drugs, while others are class specific. High-risk agents should be closely monitored based on patient characteristics (gender, age, weight, creatinine clearance, number of comorbidities) and drug administration (dosage, administration route, number of concomitant drugs).
引用
收藏
页码:1161 / 1168
页数:8
相关论文
共 50 条
  • [21] Patient risk factors for adverse drug events in hospitalized patients
    Bates, DW
    Miller, EB
    Cullen, DJ
    Burdick, L
    Williams, L
    Laird, N
    Petersen, LA
    Small, SD
    Sweitzer, BJ
    Vander Vliet, M
    Leape, LL
    ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (21) : 2553 - 2560
  • [22] ADVERSE CHILDHOOD EVENTS AS RISK FACTORS FOR ALCOHOL AND DRUG DEPENDENCE
    Chan, G.
    Douglas, K.
    Gelernter, J.
    Arias, A. J.
    Anton, R. F.
    Weiss, R. D.
    Bardy, K.
    Poling, J.
    Farrer, L.
    Kranzler, H. R.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2009, 33 (06) : 69A - 69A
  • [23] Risk factors for the development of adverse drug events in hospitalized patients
    van den Bemt, PMLA
    Egberts, ACG
    Lenderink, AW
    Verzijl, JM
    Simons, KA
    van der Pol, WSCJM
    Leufkens, HGM
    PHARMACY WORLD & SCIENCE, 2000, 22 (02): : 62 - 66
  • [24] Prevalence and risk factors for adverse drug events: a systematic review and meta-analysis
    Souza, T. T.
    Godoy, R. R.
    Ziegelmann, P. K.
    Fernandez-Llimos, F.
    Correr, C. J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1335 - 1336
  • [25] Risk factors for the development of adverse drug events in hospitalized patients
    P.M.L.A. van den Bemt
    A.C.G. Egberts
    A.W. Lenderink
    J.M. Verzijl
    K.A. Simons
    W.S.C.J.M. van der Pol
    H.G.M. Leufkens
    Pharmacy World and Science, 2000, 22 : 62 - 66
  • [26] Identification of risk factors for adverse drug events in a general hospital
    Pisetta, Leticia Mara
    Tonin, Fernanda Zanardo
    Akiyoshi, Fernando Kenji
    Santos, Fabio Andre
    Fernandes, Daniel
    INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE, 2024, 36 (03)
  • [27] Pediatric Drug Safety Surveillance: A 10-Year Analysis of Adverse Drug Reaction Reporting Data in Calabria, Southern Italy
    Leporini, Christian
    De Sarro, Caterina
    Palleria, Caterina
    Caccavo, Iolanda
    Piro, Brunella
    Citraro, Rita
    De Sarro, Giovambattista
    DRUG SAFETY, 2022, 45 (11) : 1381 - 1402
  • [28] Pediatric Drug Safety Surveillance: A 10-Year Analysis of Adverse Drug Reaction Reporting Data in Calabria, Southern Italy
    Christian Leporini
    Caterina De Sarro
    Caterina Palleria
    Iolanda Caccavo
    Brunella Piro
    Rita Citraro
    Giovambattista De Sarro
    Drug Safety, 2022, 45 : 1381 - 1402
  • [29] Adverse events associated with donor plateletpheresis: A 10-year experience from Vojvodina, Serbia
    Obradovic, Zorana Budakov
    Bujandric, Nevenka
    Grujic, Jasmina
    VOJNOSANITETSKI PREGLED, 2022, 79 (08) : 751 - 756
  • [30] Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience
    Cruz, Conrad Russell
    Hanley, Patrick J.
    Liu, Hao
    Torrano, Vicky
    Lin, Yu-Feng
    Arce, James A.
    Gottschalk, Stephen
    Savoldo, Barbara
    Dotti, Gianpietro
    Louis, Chrystal U.
    Leen, Ann M.
    Gee, Adrian P.
    Rooney, Cliona M.
    Brenner, Malcolm K.
    Bollard, Catherine M.
    Heslop, Helen E.
    CYTOTHERAPY, 2010, 12 (06) : 743 - 749